Cynata Therapeutics Limited Financial Overview
Cynata Therapeutics Limited's market cap is currently AU$59.36M. The company's EPS TTM is AU$-0.025; its P/E ratio is ―; Cynata Therapeutics Limited is scheduled to report earnings on August 28, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
